Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
16-18 November 2027
Congress Center HamburgHamburg, Germany

Jigna Dave
Regulatory Manager, CMC at GSK
Speaker

Profile

Jigna Dave is a Senior Manager, Regulatory Affairs CMC at GSK, with experience delivering global regulatory strategies for pharmaceutical development programs. She specializes in Chemistry, Manufacturing and Controls (CMC) for small molecules and oligonucleotide therapeutics, supporting products from early clinical development through registration and lifecycle management.

Throughout her career, Jigna has partnered with multidisciplinary teams to drive successful regulatory submissions and health authority engagements across global markets. Her expertise includes clinical trial applications, late-stage development, regulatory policy interpretation, and strategic CMC planning for innovative medicines.

Jigna is particularly interested in the evolving regulatory landscape for advanced therapeutics and the role of regulatory science in accelerating the development of medicines for patients worldwide.

Agenda Sessions

  • Regulatory CMC Strategies for Oligonucleotides

    , 10:45